Pathological Insights into QSM in Substantia Nigra: Tau, Neurons, and Iron Roles

Overview

This study investigated the neuropathologic contributors to quantitative susceptibility mapping (QSM) values in the substantia nigra (SN) across neurodegenerative diseases. By quantifying iron deposition, tau burden, and pigmented neuron density in postmortem SN tissue, the research delineated their independent effects on magnetic susceptibility measured antemortem by MRI.

Background

Quantitative susceptibility mapping (QSM) is an MRI technique sensitive to tissue magnetic properties, increasing with iron accumulation, myelin loss, and neuroinflammation. Elevated QSM values in the substantia nigra have been reported in Lewy body disease (LBD), tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), and Alzheimer’s disease (AD). However, the specific neuropathologic factors contributing to QSM changes remain incompletely understood. Prior studies lacked comprehensive iron quantification alongside tau and neuronal measures, limiting interpretation of QSM in these disorders.

Data Highlights

The study included 59 participants with autopsy-confirmed neurodegenerative diagnoses who underwent antemortem MRI with multi-echo T2* gradient echo sequences. Neuropathologic evaluation quantified iron deposition (Prussian blue staining), tau burden (phosphorylated tau IHC), and pigmented neuron density in four SN quadrants. Clinical assessments included cognitive testing and parkinsonism severity scales. Digital pathology with machine learning enabled objective regional quantification of histologic parameters correlated with QSM values.

Key Findings

• QSM values in the substantia nigra correlate positively with iron deposition and tau burden but negatively with pigmented neuron density.
• Iron accumulation is a major independent contributor to increased magnetic susceptibility in the SN across neurodegenerative diseases.
• Tau pathology also independently elevates QSM values, particularly in tauopathies like PSP and CBD.
• Loss of pigmented neurons reduces tissue susceptibility, reflecting neurodegeneration severity.
• Regional analysis across SN quadrants reveals spatial heterogeneity in iron, tau, and neuron density contributing to QSM variability.
• α-Synuclein burden and amyloid-β pathology in the SN do not significantly correlate with QSM measures in this cohort.

Clinical Implications

QSM can serve as a noninvasive biomarker reflecting combined effects of iron accumulation, tau pathology, and neuronal loss in the substantia nigra. Understanding these independent contributors aids interpretation of QSM changes in Parkinsonian and tau-related disorders. This knowledge may improve diagnostic accuracy and monitoring of disease progression using MRI-based susceptibility measures.

Conclusion

This study clarifies that iron deposition, tau burden, and pigmented neuron density independently influence QSM values in the substantia nigra. These findings enhance the neuropathologic understanding of QSM alterations in neurodegenerative diseases and support its utility as a biomarker integrating multiple pathological processes.

References

1. Wang et al. 2023 -- Clinicopathologic study of tau and glial density contributions to SN susceptibility
2. Mayo Clinic ADRC and MCSA cohorts 2018-2023 -- Neuropathologic and MRI data
3. DLB Consortium criteria 2017 -- Lewy body pathology classification
4. NIA-AA criteria 2012 -- Alzheimer’s disease neuropathologic change